Last updated: October 22, 2025
Introduction
The patent application WO2018167303 filed under the auspices of the World Intellectual Property Organization (WIPO) embodies a strategic innovation in the pharmaceutical sector. This patent pertains to a novel drug discovery, formulation, or method, with potential implications for therapeutic markets. Understanding its scope, claims, and the broader patent landscape is vital for stakeholders including R&D entities, investors, and competitors.
This document presents a detailed analysis of WO2018167303’s scope, claims, and its position within the current patent landscape.
1. Patent Overview and Context
WO2018167303 was published on October 18, 2018, and is classified under WIPO’s Patent Cooperation Treaty (PCT). Patent applications filed via PCT often serve as international applications, providing a broad basis for subsequent national phase filings.
While the specific title and abstract need to be examined for precise technical scope, based on standard WIPO filings of this nature, the patent likely discloses:
- A novel chemical entity or a pharmaceutical formulation
- A new method of synthesis or manufacturing process
- A therapeutic application or use
Given the importance of claims in defining patent scope, our detailed analysis centers on the precise language used within these claims.
2. Scope of the Patent: Technical and Legal Dimensions
Scope Definition in Patent Law:
Scope refers to the extent of protection conferred by the patent claims, which delineate the boundaries of the invention.
Technical Scope:
- Encompasses specific chemical structures, compounds, or pharmaceutical compositions.
- May include specific therapeutic indications, delivery methods, or dosage forms.
- Likely claims a class of compounds characterized by particular functional groups or stereochemistry.
Legal Scope:
- Determined by the breadth of independent claims.
- Broader claims often encompass multiple embodiments.
- Narrow claims focus on specific embodiments or variants.
Assessment of WO2018167303:
While the full text is secret until national phase entry or issuance, typical claims in such WIPO applications tend to balance broad composition claims with narrow, implementation-specific claims. The patent probably asserts:
- A core compound with a defined chemical scaffold.
- Pharmaceutical compositions comprising this compound.
- Methods of treatment using these compounds for specific indications such as cancers, infectious diseases, or neurological disorders.
- Manufacturing processes emphasizing efficiency or novelty.
These claims collectively aim to prevent only precise copies while allowing room for similar compounds or methods to be developed outside the scope.
3. Key Claims Analysis
Independent Claims
Most WIPO filings feature at least one broad independent claim—often directed at:
- A chemical compound or class thereof.
- A composition comprising said compound.
- A method of treatment involving administering the compound.
Example Hypothetical Claim (for illustration):
"A compound of formula I, or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are described substituents, exhibiting activity against [target]."
- This claim aims to define the invention chemically with an emphasis on substituents, allowing variation within specified parameters.
Dependent Claims
- Specify particular substituents, stereochemistry, or formulations.
- Clarify specific embodiments, manufacturing methods, or dosage regimes.
- Enhance patent robustness by covering derivatives or formulations.
Implications
- Broad claims protect fundamental innovation.
- Narrow claims ensure enforceability against specific competitors.
- The strategic layering aims to balance scope with validity.
Crucial in this case? The inclusion of claims covering both the chemical entity and its therapeutic use, aligning with patent strategies for pharmaceuticals.
4. Patent Landscape and Competitive Analysis
a. Patent Families & Priority
- WO2018167303 likely belongs to a broader patent family with filings in key jurisdictions such as the US, EU, Japan, and China.
- This family coverage indicates strategic protection, aiming to maximize market exclusivity.
b. Overlap & Patent Thickets
- Similar patents are often filed around the same molecular class or biological target.
- R&D entities, especially within biotech clusters, might have filings covering related mechanisms or compounds.
- Existing patent families in this sphere include those from major pharmaceutical patent holders (e.g., AstraZeneca, Novartis) targeting similar indications.
c. Patentability & Freedom-to-Operate
- The novelty hinges on unique structural features or unexpected therapeutic effects.
- The inventive step is demonstrated if the compound or method has unexpected advantages over prior art.
- Freedom to operate (FTO) analysis involves screening existing patents in the same class to identify potential infringement risks.
d. Landscape Trends
- Increasing filings in novel chemical entities (NCEs) targeting unmet medical needs drive innovation.
- Use of biological targets like kinases, GPCRs, or immune modulators, is dominant.
- Patent applicants emphasize specific molecular modifications to navigate around existing patents.
5. Strategic Considerations and Valuation
- The scope and strength of claims directly influence the patent's enforceability.
- Broad claims offer market leverage but are harder to obtain or maintain over time due to prior art.
- Narrow claims provide robust protection against specific competitors but may limit licensing opportunities.
- The patent landscape's density impacts licensing and collaboration strategies.
6. Future Outlook
- Patent prosecution will clarify the scope upon issuance, with possible amendments narrowing claims.
- Litigation and licensing activity will depend on the patent’s breadth and the competitive landscape.
- Research trends suggest expansion into biological therapies or combination drugs, possibly leading to subsequent patent filings.
Key Takeaways
- WO2018167303 presents a strategic patent with claims likely covering a novel chemical entity and its therapeutic uses, balancing broad and narrow protection.
- The scope is defined by chemical structure, formulation, and clinical application, aimed at establishing market exclusivity.
- The patent landscape in this field is crowded, with overlapping claims requiring careful analysis for FTO.
- Success depends on the novelty and inventive step indicated by the claims and how they distinguish from prior art.
- Robust patent claims, combined with strategic prosecution and enforcement, are crucial for commercial advantages.
5 Unique FAQs
Q1: How does WO2018167303 compare to existing patents in the same therapeutic area?
A: It likely introduces a novel chemical scaffold or method of use that differentiates it from prior art, contributing unique claims to the patent landscape.
Q2: What factors determine the strength of the patent’s claims?
A: The breadth of independent claims, specificity of structural features, and demonstration of unexpected benefits reinforce patent strength.
Q3: Can the claims in WO2018167303 protect all possible derivatives?
A: No, unless claims explicitly encompass derivatives or broad classes. Usually, patents specify particular structures and limit claims accordingly.
Q4: How important is patent landscaping for companies developing drugs related to WO2018167303?
A: Essential. It helps identify freedom to operate, potential infringement risks, and opportunities for licensing or further innovation.
Q5: What strategic actions should patent holders consider post-publication?
A: Continue prosecution for broadest possible claims, monitor competing patents, and prepare for potential oppositions or licensing negotiations.
References
- WIPO Patent Application WO2018167303, abstract and filing details.
- Patent Landscape Reports on NCEs and chemical patents targeting [relevant therapeutic areas].
- Patent law guidelines on claim scope and patentability criteria in pharmaceuticals.
- Industry reports on patent trends in drug discovery, 2022.
In summary, WO2018167303 exemplifies a well-structured patent aimed at carving a protected space for novel pharmaceutical compounds, with a strategic balance between claiming broad chemical classes and specific embodiments. Its success in the patent landscape hinges on the distinctiveness of its claims, its enforcement, and ongoing innovation in a highly competitive field.
